GOVX
GeoVax Labs, Inc.
There isn't enough reported data to score GOVX yet.
GOVX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
GOVX's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
GOVX PE Valuation
GOVX has no meaningful PE right now: it lost money over the past year.
GOVX Forward outlook
There aren't enough analyst estimates for GOVX to show an outlook.
GOVX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$5,728.74 | +$1,741.26 |
| Q2 2024 | -$8,062.74 | -$1,942.74 |
| Q1 2024 | -$8,848.74 | -$3,088.74 |
| Q4 2023 | -$8,716.74 | -$1,246.74 |
| Q3 2023 | -$7,470.00 | +$18,810.00 |
| Q2 2023 | -$6,120.00 | +$21,420.00 |
| Q1 2023 | -$5,760.00 | +$22,050.00 |
| Q4 2022 | -$7,470.00 | +$19,890.00 |
GOVX lost $207.36 per share over the past year, a smaller loss than the year before.
GOVX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $852.3K | +183% |
| Q1 2022 | $81.5K | -26% |
| Q4 2021 | $165K | -34% |
| Q3 2021 | $30.4K | -93% |
| Q2 2021 | $79.7K | -82% |
| Q1 2021 | $110.4K | -85% |
| Q4 2020 | $251.6K | -6.3% |
GOVX's revenue has slid since its 2024 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -636% | +1048 points |
| Q1 2025 | -330% | N/A |
| Q4 2024 | -965% | N/A |
| Q3 2024 | -210% | N/A |
| Q2 2024 | -1684% | N/A |
| Q1 2022 | -2978% | -1562 points |
| Q4 2021 | -8331% | -7800 points |
| Q3 2021 | -6416% | -6311 points |
GOVX's operating margin was −636% last quarter, up 1048 points from the same quarter a year ago.
GOVX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.3M | +$1.9M |
| Q2 2026 | -$3.7M | +$687K |
| Q1 2026 | -$3.5M | +$2.4M |
| Q4 2025 | -$5M | +$2.8M |
| Q3 2025 | -$6.2M | +$3.1M |
| Q1 2025 | -$6M | -$298.8K |
| Q4 2024 | -$7.8M | +$2.5M |
| Q3 2024 | -$9.3M | -$4.2M |
GOVX has burned cash in almost every quarter: −$16M over the past year, against −$24M the year before.
GOVX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +107% | +203K shares |
| 1 year | +1064% | +360K shares |
| 3 years | +13295% | +391K shares |
| 5 years | +452256% | +393K shares |
GOVX has 393,550 diluted shares, up 1064% from a year ago.
GOVX Net Leverage
GOVX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GOVX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.7 | Oversold |
| Stochastic | 1.4 | Oversold |
GOVX's weekly RSI is 29 (oversold) and its Stochastic is 1 (oversold).
GOVX PE vs Healthcare Sector
GOVX has no meaningful PE right now: it lost money over the past year.
GOVX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.42 | 62% below |
| 20 week MA | $12.9 | 84% below |
| 50 week MA | $43.4 | 95% below |
| 100 week MA | $349.0 | 99% below |
| 200 week MA | $1,907.6 | 100% below |
GOVX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
GOVX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $143,928.0 | $29,520.0 | -79% |
| 2021 | $29,520.0 | $36,180.0 | +23% |
| 2022 | $36,180.0 | $5,106.5 | -86% |
| 2023 | $5,106.5 | $3,249.1 | -36% |
| 2024 | $3,249.1 | $1,476.0 | -55% |
| 2025 | $1,476.0 | $108.7 | -93% |
| 2026 YTD | $108.7 | $2.04 | -98% |
GOVX has finished four years in a row lower, and it's down 98% so far in 2026.